News from gbi research A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Dec 14, 2016, 10:11 ET Cancer Immunotherapies Market to Grow by Over $58 Billion by 2022 as Innovation Thrives, Says GBI Research

A new report from business intelligence provider GBI Research - Global Cancer Immunotherapies Market to 2022 - states that the market size for cancer ...


Dec 08, 2016, 11:00 ET Big Data is Already Providing Commercial Benefits to Pharma Companies, Says GBI Research

Big Data simply refers to any data set which is too large to store, process or analyze using traditional database software and hardware. As...


Dec 01, 2016, 11:00 ET Alzheimer's Patients may Benefit Significantly From an Array of Diabetes Treatments, Says GBI Research

A new Analyst View from business intelligence provider GBI Research - Repurposing Type 2 Diabetes Mellitus Drugs for Alzheimer's Disease - states...


Nov 29, 2016, 11:25 ET Asia-Pacific Anti-hypertensive Therapeutics Market will Increase by Almost $8 Billion by 2022, says GBI Research

A new report from business intelligence provider GBI Research - Anti-hypertensive Therapeutics in Asia-Pacific Markets to 2022 - states that the...


Nov 28, 2016, 09:00 ET Unmet Needs in Type 2 Diabetes Mellitus Market Leave Ample Opportunity for Investment, Says GBI Research

A new report from business intelligence provider GBI Research - Frontier Pharma: Type 2 Diabetes Mellitus - states that the increasing demand for...


Nov 23, 2016, 10:00 ET Healthcare Sector Faces Significant Investment Barriers due to Pricing Pressures and Declining R&D Productivity, Says GBI Research

A new report from business intelligence provider GBI Research - Strategic Trends in Private Equity and Venture Capital Funding for Healthcare -...


Nov 22, 2016, 09:00 ET Asthma Treatment's Significant Unmet Needs May be Addressed By Calcilytics, Says GBI Research

A new whitepaper from business intelligence provider GBI Research - An Exploration of Novel and Repositioned Calcium Transport Mediators as...


Nov 21, 2016, 10:00 ET Uro-oncology Space set for Transformation by Pipeline Immune Checkpoint Inhibitors, Says GBI Research

A new Analyst View from business intelligence provider GBI Research - Urological Cancer Treatment Landscape to be Transformed by the Approval of...


Nov 17, 2016, 09:00 ET Cancer Vaccines Market Will Record Impressive Growth of Around $5 Billion by 2022, Says GBI Research

A new report from business intelligence provider GBI Research - Global Cancer Vaccines Market to 2022 - states that the cancer vaccines market is set ...


Nov 16, 2016, 10:00 ET Private Equity and Venture Capital Funding Crucial for Healthcare Innovation, says GBI Research

Private equity (PE) and venture capital (VC) funds have been important participants in a wide range of industries for many decades - particularly the ...


Nov 14, 2016, 11:00 ET Pharmaceutical Companies Turn Attention Towards Synthetic Cannabinoids as Evidence of Their Therapeutic Properties Strengthens, Says GBI Research

A new whitepaper from business intelligence provider GBI Research - The Emerging Field of Cannabinoid-Based Products - states that despite legal...


Nov 09, 2016, 11:00 ET Increased Development of Highly-targeted Biologics Set to Change Composition of Asthma Therapeutics Market, Says GBI Research

A new report from business intelligence provider GBI Research - Frontier Pharma: Asthma Therapeutics - states that the asthma therapeutics market is...


Jul 21, 2016, 09:01 ET Stem Cell Therapies Facing Commercial Challenges Despite Promising Pipeline, Says GBI Research

A new report from business intelligence provider GBI Research - Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D...


Jul 19, 2016, 07:00 ET APAC Osteoporosis Market Will Rise From $4.5 Billion in 2015 to $7.7 Billion by 2022, Says GBI Research

A new report from business intelligence provider GBI Research - Osteoporosis Therapeutics in Asia -Pacific Markets to 2022 - states that the...


Jun 30, 2016, 07:00 ET Urological Cancers Market Set to Approach $36 Billion by 2022, Says GBI Research

A new report from business intelligence provider GBI Research - Global Urological Cancer Market to 2022 - states that the urological cancers market,...


Jun 28, 2016, 09:00 ET Diabetes Complications Pipeline Has High Potential for Change as 30% of Products Considered First-in-Class, says GBI Research

A new report from business intelligence provider GBI Research - Frontier Pharma: Diabetic Complications - states that the diabetes complications...


Jun 21, 2016, 11:00 ET Hematological Cancers Space Abounds with Innovation, Most Notably in the Leukemia Segment, Says GBI Research

A new report from business intelligence provider GBI Research - Frontier Pharma: Hematological Cancers - states that of the three major indications...


Jun 16, 2016, 09:00 ET First-in-class Products Show Way Forward for Pharmaceutical Industry, Says GBI Research

A new report from business intelligence provider GBI Research - Innovation Tracking Factbook 2016 - states that, with the cost of bringing a single...


May 12, 2016, 11:00 ET Significant Unmet Needs in Veterinary Medicine Offer Opportunities for Human Drugs, Says GBI Research

A new report from business intelligence provider GBI Research - Human Drugs For Veterinary Use - Current Trends and Future Commercial Prospects for...


May 05, 2016, 11:00 ET Asia-Pacific Non-Small Cell Lung Cancer Market to Reach Almost $5 Billion by 2022, says GBI Research

A new report from business intelligence provider GBI Research - Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2022 - states that ...


May 03, 2016, 11:00 ET Global Dermatology Market Hit $20 Billion in 2015 and Will Reach $33.7 Billion by 2022, Says GBI Research

A new report from business intelligence provider GBI Research - Global Dermatology Market to 2022 - states that the global dermatology market is set...


Apr 28, 2016, 08:00 ET Hematological Cancers Market to Hit $70.1 Billion by 2022 Despite Key Patent Expirations, Says GBI Research

A new report from business intelligence provider GBI Research - Global Hematological Cancers Market to 2022 - states that the market for...


Apr 14, 2016, 09:00 ET Global Viral Infections Market Set to Surpass $117 Billion by 2021, says GBI Research

A new report from business intelligence provider GBI Research - Global Viral Infections Market to 2021 - states that the global viral infections...


Apr 12, 2016, 11:00 ET Despite its Weak Pipeline, Schizophrenia Market May Benefit from Drugs Used in Similar Indications, Says GBI Research

A new report from business intelligence provider GBI Research - Frontier Pharma: Schizophrenia and Associated Indications - states that although the...


Apr 08, 2016, 07:00 ET Global Non-Hematological Cancers Market to Hit $140.8 Billion by 2021, says GBI Research

A new report from business intelligence provider GBI Research - Global Non-Hematological Cancers Market to 2021 - states that the global treatment...